The price of Humira's biosimilars can uncloak the secret villain of US drug pricing Quartz • March 23, 2023, 2:30 pm Pharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. But Americans can fin...Read more